RecruitMe Clinical Trial

METIS: Pivotal, open-label, randomized study of radiosurgery with or without Tumor Treating Fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC)
A study for patients with brain metastases from non-small cell lung cancer (NSCLC) using radiosurgery
Sponsor:NovoCure Ltd.
Enrolling:Male and Female Patients
IRB Number:AAAR1011
U.S. Government ID:NCT02831959
Contact: Teri Kreisl: 212-342-0571 / tnk2109@cumc.columbia.edu
Additional Study Information:

The purpose of this study is to obtain information on the safety and effectiveness of NovoTTF-100M (study device) in subjects with brain metastases (tumors) as a result of non-small cell lung cancer.

Do You Qualify?
Have you been diagnosed with a brain tumor as a result of having NSCLC?YesNo
Are you at least 18 years of age?YesNo
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:

Teri Kreisl

tnk2109@cumc.columbia.edu

212-342-0571

YesYes2